STOCK TITAN

Science 37® to Present at the Cowen 42nd Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Science 37 Holdings, Inc. (Nasdaq: SNCE) announced its participation in the Cowen 42nd Annual Health Care Conference, scheduled for March 7, 2022, at 1:30 p.m. Eastern Time. The presentation will be accessible via a live and archived webcast on the company’s Investor Relations website. Science 37 aims to improve access to clinical trials through its Agile Clinical Trial Operating System, which supports diverse patient populations and faster enrollment rates. The company focuses on decentralized trials to enhance efficiencies in clinical research.

Positive
  • None.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Cowen 42nd Annual Health Care Conference.

Science 37’s management is scheduled to present on Monday, March 7, 2022, at 1:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investor Relations” section of the company’s website at: https://investors.science37.com.

About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 Agile Clinical Trial Operating System (OS) supports today’s more agile clinical research designs with its full stack, end-to-end technology platform and centralized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, provider communities, and data and devices. Configurable to enable almost any study type, the Science 37 OS enables up to 15x faster enrollment, 28% better retention and 3x more diverse patient population with industry-leading workflow orchestration, evidence generation and data harmonization. For more information, visit https://www.science37.com.

MEDIA INQUIRIES

Margie Kooman
Science 37
Phone: (984) 377-3737
Email: pr@science37.com

INVESTOR RELATIONS:
Caroline Paul
Gilmartin Group
Investors@science37.com


FAQ

When is Science 37 participating in the Cowen 42nd Annual Health Care Conference?

Science 37 will present on March 7, 2022, at 1:30 p.m. Eastern Time.

How can I access Science 37's presentation at the conference?

You can access the live and archived webcast on Science 37's Investor Relations website.

What is the focus of Science 37's Agile Clinical Trial Operating System?

The Agile Clinical Trial Operating System focuses on improving access to clinical research and enhancing trial efficiencies.

What are the benefits of Science 37's technology platform?

The platform enables up to 15x faster enrollment, 28% better retention, and a more diverse patient population.

What is the stock symbol for Science 37?

The stock symbol for Science 37 is SNCE.

Science 37 Holdings, Inc.

NASDAQ:SNCE

SNCE Rankings

SNCE Latest News

SNCE Stock Data

34.66M
4.13M
16.89%
52.18%
0.23%
Health Information Services
Healthcare
Link
United States
Research Triangle Park